In this study, we confirmed the abnormally higher expression of FoxO3 in various steatosis cell models, animal models and patients with NAFLD, implying a close link between FoxO3 and fatty liver. Here, FOXO3 is linked to metabolic dysfunction-associated steatotic liver disease.